GlassScriptPhysician profile
Clifford S Mowery
NPI 1629031026
$5,007.34
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $1,346 · 2021: $2,172.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $998.46 | 2019-2021 | |
| Novo Nordisk INC | $684.13 | 2019-2021 | |
| Lilly USA, LLC | $500.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $412.25 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.51 | 2019-2021 | |
| Amgen INC. | $381.82 | 2019-2021 | |
| Pfizer INC. | $308.88 | 2019-2021 | |
| Abbvie INC. | $251.23 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $159.26 | 2019-2021 | |
| Amarin Pharma, INC. | $140.25 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $121.86 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $103.80 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $98.94 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $72.21 | 2019-2021 | |
| Abbott Laboratories | $66.49 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.48 | 2019-2021 | |
| Glaxosmithkline, LLC. | $52.19 | 2019-2021 | |
| Edwards Lifesciences Corporation | $41.35 | 2020 | |
| Dexcom, INC. | $38.24 | 2021 | |
| Eisai INC. | $32.65 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $32.27 | 2021 | |
| Medtronic USA, INC. | $15.65 | 2019 | |
| Daiichi Sankyo INC. | $13.59 | 2019 | |
| Sanofi Pasteur INC. | $13.44 | 2020 | |
| Shire North American Group INC | $12.06 | 2019 | |
| Hikma Pharmaceuticals USA | $11.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Mowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.